Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    19179464 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Lenalidomide Maintenance Therapy for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Lenalidomide
2 Completed Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
Conditions: Smoldering Myeloma;   Monoclonal Gammopathy of Undetermined Significance
Intervention:
3 Active, not recruiting A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
Conditions: Multiple Myeloma;   Myeloma;   Smoldering Multiple Myeloma
Intervention: Drug: (Anti-KIR)
To Top

† Indicates status has not been verified in more than two years